1. Home
  2. NAZ vs ENLV Comparison

NAZ vs ENLV Comparison

Compare NAZ & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Arizona Quality Municipal Income Fund

NAZ

Nuveen Arizona Quality Municipal Income Fund

HOLD

Current Price

$12.46

Market Cap

162.0M

Sector

Finance

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$4.78

Market Cap

149.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAZ
ENLV
Founded
1992
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.0M
149.0M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
NAZ
ENLV
Price
$12.46
$4.78
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$20.00
AVG Volume (30 Days)
18.8K
377.1K
Earning Date
01-01-0001
05-29-2026
Dividend Yield
3.69%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.50
$0.43
52 Week High
$13.42
$7.64

Technical Indicators

Market Signals
Indicator
NAZ
ENLV
Relative Strength Index (RSI) 41.05 65.46
Support Level $12.35 $0.79
Resistance Level $12.66 $7.64
Average True Range (ATR) 0.16 0.45
MACD 0.00 0.36
Stochastic Oscillator 20.01 59.51

Price Performance

Historical Comparison
NAZ
ENLV

About NAZ Nuveen Arizona Quality Municipal Income Fund

Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: